Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Van Lancker

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Statistics in Medicine|October 22, 2019
Evaluating futility of a binary clinical endpoint using early read-outsKelly Van Lancker, An Vandebosch, Stijn Vansteelandt, et al.
Biometrics|June 17, 2026
Practical considerations when using the covariate-adjusted log-rank test for the analysis of time-to-event endpoints in oncology trialsDaniel Backenroth, Sanne Roels, Shiva Dibaj, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?Cornelia Ursula Kunz, Silke Jörgens, Frank Bretz, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Statistics in Medicine|October 22, 2019
Evaluating futility of a binary clinical endpoint using early read-outsKelly Van Lancker, An Vandebosch, Stijn Vansteelandt, et al.
Biometrics|June 17, 2026
Practical considerations when using the covariate-adjusted log-rank test for the analysis of time-to-event endpoints in oncology trialsDaniel Backenroth, Sanne Roels, Shiva Dibaj, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Clinical Trials Impacted by the COVID-19 Pandemic: Adaptive Designs to the Rescue?Cornelia Ursula Kunz, Silke Jörgens, Frank Bretz, et al.
Pageof 2